Year: 2022

FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVERRULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.      KEY INFORMATION(a)   Full name of discloser Invesco Ltd.(b)   Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree Amgen Inc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)  (e)   Date position held/dealing undertaken For...

Stockwik Förvaltning AB (publ) har per idag den 1 december 2022 förvärvat samtliga aktier i Fysrehab Lidköping AB (”Fysrehab”). Stockwik tillträdde även samtliga aktier per idag. Fysrehab är en rehabklinik i Lidköping med målsättningen att vara det självklara valet för de patienter som är i behov av någon form av rehabilitering i Lidköping och i Västra Götalandsregionen. Med cirka femton medarbetare erbjuder bolaget spetskompetens inom flera olika områden, bl a sjukgymnastik, arbetsterapi, logopedi och neuroteam. ”Vi är oerhört glada att välkomna Björn, Carina och alla andra medarbetare till Stockwik! Fysrehab är ett välskött bolag med nöjda kunder och vi ser fram mot att få vara med på deras fortsätta resa”, säger David Andreasson, VD för Stockwik. ”Med Stockwik kommer vi på Fysrehab att kunna ta tillvara på en större aktörs möjligheter,...

FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVERRULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.      KEY INFORMATION(a)   Full name of discloser Invesco Ltd.(b)   Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree Horizon Therapeutics PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)  (e)   Date position held/dealing...

FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVERRULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.      KEY INFORMATION(a)   Full name of discloser Invesco Ltd.(b)   Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree Amgen Inc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)  (e)   Date position held/dealing undertaken For...